Nutshell Therapeutics
Huangpu
About Nutshell Therapeutics
Nutshell Therapeuticstein drug discovery platform, composed of a well-integrated set of computational modules and experimental tools based on a proprietary AI algorithm and deep know-how derived from biochemistry and biophysics, possesses the capability to discover a host of drug entities, including various types of protein activators and subtype/mutation-selective small molecules.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $75.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: allonutshell.cn
- Phone: 86-51061769
Industries & Categories
Artificial Intelligence (AI), Health Care, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/nutshell-therapeutics-56037 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.